Black, S., Wilcock, G., Haworth, J., Hendrix, S., Zavitz, K., Christensen, D., . . . Swabb, E. (2006). Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study.
Citace podle Chicago (17th ed.)Black, S., et al. Efficacy and Safety of MPC-7869 (R-flurbiprofen), a Selective Ab42-lowering Agent, in Mild Alzheimer's Disease (AD): Results of a 12-month Phase 2 Trial and 1-year Follow-on Study. 2006.
Citace podle MLA (9th ed.)Black, S., et al. Efficacy and Safety of MPC-7869 (R-flurbiprofen), a Selective Ab42-lowering Agent, in Mild Alzheimer's Disease (AD): Results of a 12-month Phase 2 Trial and 1-year Follow-on Study. 2006.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..